Dear JPR Readers,
We are pleased to present the second issue of 2025. I would like to thank all the editors, reviewers, authors, and the publishing house for their valuable contributions to this issue. Our goal is to contribute to the literature with each new issue and to advance JPR further.
In this issue, we present studies on new biomarkers in non-alcoholic fatty liver disease, analysis of gallbladder stones, evaluating the outcomes of late preterm births, and the effects of aminoglycoside use on hearing in cystic fibrosis. Additionally, this issue includes studies evaluating changes in air pollution and respiratory problems, autoimmune thyroiditis, and epilepsy with occipital discharges. We also share a case series evaluating the control of coagulation problems with sodium benzoate in argininemia. A case presentation on tocilizumab treatment for rare acute necrotizing encephalopathy associated with the dengue/flavi virus, as well as a letter to the editor about clinical and peripheral blood smear findings for diagnosing Chanarin-Dorfman syndrome, also contribute valuable insights to this issue.
We hope that this issue, with its research articles and case presentations, will be of scientific interest to you. We look forward to connecting with you again as readers and authors in the upcoming issues of JPR.
Best wishes,
Dr. Yeliz Çağan Appak
